Picard Medical is trading 12.45% down now at $8.36 after Bragar Eagel & Squire announced an investigation on August 25, 2026, into potential fiduciary-duty breaches.
- The inquiry cites alleged social-media promotion, nominee accounts, coordinated share activity, and omitted risk disclosures.
- Shares closed at $9.55 on August 25 after an 86.16% gain, following a $5.13 close on August 24 after a 59.81% increase.